Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans

被引:172
|
作者
Sullivan, DJ [1 ]
Moran, GP [1 ]
Pinjon, E [1 ]
Al-Mosaid, A [1 ]
Stokes, C [1 ]
Vaughan, C [1 ]
Coleman, DC [1 ]
机构
[1] Univ Dublin Trinity Coll, Dublin Dent Sch & Hosp, Dept Oral Med Oral Surg & Oral Pathol, Microbiol Res Unit, Dublin 2, Ireland
关键词
Candida dubliniensis; Candida albicans; epidemiology; virulence; resistance;
D O I
10.1016/S1567-1356(03)00240-X
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Candida dubliniensis is a pathogenic yeast species that was first identified as a distinct taxon in 1995. Epidemiological studies have shown that C dubliniensis is prevalent throughout the world and that it is primarily associated with oral carriage and oropharyngeal infections in human immunodeficiency virus (HIV)-infected and acquired immune deficiency syndrome (AIDS) patients. However, unlike Candida albicans, C dubliniensis is rarely found in the oral microflora of normal healthy individuals and is responsible for as few as 2% of cases of candidemia (compared to approximately 65% for C albicans). The vast majority of C dubliniensis isolates identified to date are susceptible to all of the commonly used antifungal agents, however, reduced susceptibility to azole drugs has been observed in clinical isolates and can be readily induced in vitro. The primary mechanism of fluconazole resistance in C dubliniensis has been shown to be overexpression of the major facilitator efflux pump Mdr1p. It has also been observed that a large number of C dubliniensis strains express a non-functional truncated form of Cdr1p, and it has been demonstrated that this protein does not play a significant role in fluconazole resistance in the majority of strains examined to date. Data from a limited number of infection models reflect findings from epidemiological studies and suggest that C dubliniensis is less pathogenic than C albicans. The reasons for the reduced virulence of C dubliniensis are not clear as it has been shown that the two species express a similar range of virulence factors. However, although C dubliniensis produces hyphae, it appears that the conditions and dynamics of induction may differ from those in C albicans. In addition, C. dubliniensis is less tolerant of environmental stresses such as elevated temperature and NaCl and H2O2 concentration, suggesting that C. albicans may have a competitive advantage when colonising and causing infection in the human body. It is our hypothesis that a genomic comparison between these two closely-related species will help to identify virulence factors responsible for the far greater virulence of C albicans and possibly identify factors that are specifically implicated in either superficial or systemic candidal infections. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 50 条
  • [21] Comparison of Candida albicans and Candida dubliniensis cell wall mannan and cell surface hydrophobicity
    Masuoka, J
    Hazen, KC
    GLYCOBIOLOGY, 2000, 10 (10) : 1123 - 1123
  • [22] Comparison of polar lipids from yeast and mycelial forms of Candida albicans and Candida dubliniensis
    Mahmoudabadi, AZ
    Drucker, DB
    MYCOSES, 2006, 49 (01) : 18 - 22
  • [23] Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis
    Suhail Ahmad
    Ziauddin Khan
    Mohammad Asadzadeh
    Ajmal Theyyathel
    Rachel Chandy
    BMC Infectious Diseases, 12
  • [24] Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis
    Ahmad, Suhail
    Khan, Ziauddin
    Asadzadeh, Mohammad
    Theyyathel, Ajmal
    Chandy, Rachel
    BMC INFECTIOUS DISEASES, 2012, 12
  • [25] Evaluation of tobacco agar for chlamydosporulation in Candida albicans and Candida dubliniensis
    Kumar, CPG
    Menon, T
    JOURNAL DE MYCOLOGIE MEDICALE, 2006, 16 (01): : 58 - 58
  • [26] Candida albicans and Candida dubliniensis in Periodontitis in Adolescents and Young Adults
    Jabri, B.
    Iken, M.
    Ait- Ou-amar, S.
    Rida, S.
    Bouziane, A.
    Ennibi, O. K.
    INTERNATIONAL JOURNAL OF MICROBIOLOGY, 2022, 2022
  • [27] Effect of Silver Nanoparticles (AgNPs) on Candida albicans, Candida dubliniensis and Candida guilliermondii
    Masoumizadeh, Mahnaz
    Madani, Mahboobeh
    Fatahian, Soheil
    Shakib, Pegah
    CURRENT DRUG THERAPY, 2022, 17 (01) : 50 - 55
  • [28] Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans
    Jackson, Andrew P.
    Gamble, John A.
    Yeomans, Tim
    Moran, Gary P.
    Saunders, David
    Harris, David
    Aslett, Martin
    Barrell, Jamie F.
    Butler, Geraldine
    Citiulo, Francesco
    Coleman, David C.
    de Groot, Piet W. J.
    Goodwin, Tim J.
    Quail, Michael A.
    McQuillan, Jacqueline
    Munro, Carol A.
    Pain, Arnab
    Poulter, Russell T.
    Rajandream, Marie-Adele
    Renauld, Hubert
    Spiering, Martin J.
    Tivey, Adrian
    Gow, Neil A. R.
    Barrell, Barclay
    Sullivan, Derek J.
    Berriman, Matthew
    GENOME RESEARCH, 2009, 19 (12) : 2231 - 2244
  • [29] Adherence ability of Candida africana: a comparative study with Candida albicans and Candida dubliniensis
    Romeo, Orazio
    De Leo, Filomena
    Criseo, Giuseppe
    MYCOSES, 2011, 54 (04) : E57 - E61
  • [30] Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
    Lee, Yunjin
    Puumala, Emily
    Robbins, Nicole
    Cowen, Leah E.
    CHEMICAL REVIEWS, 2021, 121 (06) : 3390 - 3411